Skip to main content

The Dilemmas of Prostate Cancer

Do the risks of aggressive treatment for early prostate cancer outweigh the benefits? This question is one of several unresolved issues faced by those who treat, and those who have, prostate cancer

00

Marc B. Garnick is Gorman Brothers Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center in Boston. He is editor in chief of Harvard Medical School’s 2024–2025 Report on Prostate Diseases.

More by Marc B. Garnick
Scientific American Magazine Vol 270 Issue 4This article was originally published with the title “The Dilemmas of Prostate Cancer” in Scientific American Magazine Vol. 270 No. 4 (), p. 72
doi:10.1038/scientificamerican0494-72